Discovering a Breakthrough in Bladder Cancer Treatment landscape

Dr Ravindran Kanesvaran, Chairman and Senior Consultant, Division of Medical Oncology,, National Cancer Centre Singapore...

January 20, 2025 | Monday | Opinion
Researchers in New Zealand win $8.3 M grant to prevent influenza

New Zealand-based University of Auckland-led project plans to develop a tool to predict the risk and mitigate the effect...

January 18, 2025 | Saturday | News
Singapore discovers potential for new colorectal cancer treatment

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have made a discov...

January 18, 2025 | Saturday | News
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) used an artificial intelligence (AI...

January 14, 2025 | Tuesday | News
etherna Immunotherapies and Dropshot Therapeutics Partner in $950M Deal to Drive RNA Therapeutic Innovation

etherna immunotherapies NV (“etherna”), a technology platform leader pioneering mRNA and lipid-based nanopar...

January 10, 2025 | Friday | News
Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership ...

January 7, 2025 | Tuesday | News
Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields

Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiven...

January 6, 2025 | Monday | News
Entrepreneur of the year 2024- Dr Jogin Desai (Eyestem Research)

A native of Ahmedabad and an expert in the field of drug development, Dr Jogin Desai incorporated his startup Eyestem Re...

January 2, 2025 | Thursday | Analysis
Australian startups receive $18.5 M to commercialise research to cure blindness, find cancer, and make childbirth safer

The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their r...

December 23, 2024 | Monday | News
Singapore bioengineers yeast microbes as targeted drug delivery systems

Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) in Singapore have developed a groundbreaking way to ...

December 18, 2024 | Wednesday | News
Major milestone for UQ spin-out’s promising MND drug in Australia

A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queenslan...

December 11, 2024 | Wednesday | News
First international progressive supranuclear palsy research and treatment centre opens in Korea

Seoul National University Bundang Hospital (SNUBH), CurePSP, Inc. and GemVax & KAEL Co., have announced the est...

December 9, 2024 | Monday | News
Alamar Biosciences establishes commercial presence in Asia Pacific region

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, has announced i...

December 7, 2024 | Saturday | News
World-first cream to treat skin cancer moves closer to reality

A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The...

November 30, 2024 | Saturday | News
Australian government invests $50 M towards finding cure for Type 1 diabetes

The Albanese government is supporting the next phase of the search for a cure for Type 1 Diabetes through a $50.1 millio...

November 28, 2024 | Thursday | News
CADENCE and Medera launch Asia’s First Multi-Centre Gene Therapy Trial in Singapore for Heart failure

The Cardiovascular Disease National Collaborative Enterprise (CADENCE) and Medera Inc. (“Merdera”)’s S...

November 19, 2024 | Tuesday | News
Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment

Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...

November 15, 2024 | Friday | News
Lilly expands R&D footprint in Singapore with S$42 M investment in new Digital Health Innovation Hub

Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...

November 14, 2024 | Thursday | News